Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 10,893 | 7,663 | 6,718 | 4,683 | 4,987 |
| Operating Income | -10,893 | -7,663 | -6,718 | -4,683 | -4,987 |
| Other Income | 217 | 85 | 104 | 150 | 186 |
| Pre-tax Income | -10,677 | -7,578 | -6,614 | -4,533 | -4,801 |
| Income Tax | 11 | 8 | 9 | 10 | 11 |
| Net Income Continuous | -10,688 | -7,586 | -6,623 | -4,543 | -4,812 |
| Net Income | $-10,688 | $-7,586 | $-6,623 | $-4,543 | $-4,812 |
| EPS Basic Total Ops | -0.28 | -0.24 | -0.22 | -0.15 | -0.15 |
| EPS Basic Continuous Ops | -0.28 | -0.24 | -0.22 | -0.15 | -0.14 |
| EPS Diluted Total Ops | -0.28 | -0.24 | -0.22 | -0.15 | -0.15 |
| EPS Diluted Continuous Ops | -0.28 | -0.24 | -0.22 | -0.15 | -0.14 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.24 | -0.22 | -0.15 | -0.16 |
| EBITDA(a) | $-10,803 | $-7,528 | $-6,638 | $-4,624 | $-4,946 |